These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11981001)

  • 41. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.
    Liang DC; Shih LY; Fu JF; Li HY; Wang HI; Hung IJ; Yang CP; Jaing TH; Chen SH; Liu HC
    Cancer; 2006 Feb; 106(4):950-6. PubMed ID: 16404744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience.
    Abbott BL; Rubnitz JE; Tong X; Srivastava DK; Pui CH; Ribeiro RC; Razzouk BI
    Leukemia; 2003 Nov; 17(11):2090-6. PubMed ID: 14523477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study on clinical and biological characteristics of childhood acute leukemia with MLL gene rearrangements].
    He J; Chen ZX; Xue YQ; Pan JL; He HL; Li JQ; Wu YF; Huang YP; Zhu LL
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):477-80. PubMed ID: 16383239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.
    Kobayashi R; Tawa A; Hanada R; Horibe K; Tsuchida M; Tsukimoto I;
    Pediatr Blood Cancer; 2007 Apr; 48(4):393-8. PubMed ID: 16550530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia.
    Huh J; Kim HJ; Jung CW; Kim HJ; Kim SH; Kim YK; Kim HJ; Shin MG; Moon JH; Sohn SK; Kim SH; Lee WS; Won JH; Mun YC; Kim H; Park J; Min WS; Kim DH;
    Am J Hematol; 2012 Oct; 87(10):961-8. PubMed ID: 22886749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of prognostic variables in childhood acute myeloid leukemia].
    Gu LJ; Tie LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Ye H; Wang YP; Dong L
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):10-3. PubMed ID: 16732931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
    Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
    Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative assessment of BAX transcript and flow cytometric expression in acute myeloid leukemia: a prospective study.
    Sharawat SK; Raina V; Kumar L; Sharma A; Bakhshi R; Vishnubhatla S; Gupta R; Bakhshi S
    Hematology; 2014 Oct; 19(7):404-11. PubMed ID: 24620954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
    Marcucci G; Mrózek K; Ruppert AS; Archer KJ; Pettenati MJ; Heerema NA; Carroll AJ; Koduru PR; Kolitz JE; Sterling LJ; Edwards CG; Anastasi J; Larson RA; Bloomfield CD
    J Clin Oncol; 2004 Jun; 22(12):2410-8. PubMed ID: 15197203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group.
    Gerbing RB; Alonzo TA; Sung L; Gamis AS; Meshinchi S; Plon SE; Bertuch AA; Gramatges MM
    J Clin Oncol; 2016 Nov; 34(31):3766-3772. PubMed ID: 27354474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in the treatment of infant acute myeloid leukemia.
    Ishii E; Kawasaki H; Isoyama K; Eguchi-Ishimae M; Eguchi M
    Leuk Lymphoma; 2003 May; 44(5):741-8. PubMed ID: 12802909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia.
    Coustan-Smith E; Ribeiro RC; Rubnitz JE; Razzouk BI; Pui CH; Pounds S; Andreansky M; Behm FG; Raimondi SC; Shurtleff SA; Downing JR; Campana D
    Br J Haematol; 2003 Oct; 123(2):243-52. PubMed ID: 14531905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Definition of a standard-risk group in children with AML.
    Creutzig U; Zimmermann M; Ritter J; Henze G; Graf N; Löffler H; Schellong G
    Br J Haematol; 1999 Mar; 104(3):630-9. PubMed ID: 10086807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia.
    Evans MW; Sung AD; Gojo I; Tidwell M; Greer J; Levis M; Karp J; Baer MR
    Leuk Lymphoma; 2012 Apr; 53(4):660-4. PubMed ID: 21942284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular diagnosis and monitoring of acute myeloid leukemia.
    Biondi A; Rambaldi A
    Leuk Res; 1996 Oct; 20(10):801-7. PubMed ID: 8960104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia.
    Webb DK; Harrison G; Stevens RF; Gibson BG; Hann IM; Wheatley K;
    Blood; 2001 Sep; 98(6):1714-20. PubMed ID: 11535502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse prognostic features in 251 children treated for acute myeloid leukemia.
    Hurwitz CA; Schell MJ; Pui CH; Crist WM; Behm F; Mirro J
    Med Pediatr Oncol; 1993; 21(1):1-7. PubMed ID: 8426571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
    Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
    Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemia.
    Metzler M; Strissel PL; Strick R; Niemeyer C; Roettgers S; Borkhardt A; Harbott J; Ludwig WD; Stanulla M; Schrappe M; Reinhardt D; Creutzig U; Beck JD; Rascher W; Repp R; Langer T
    Genes Chromosomes Cancer; 2004 Nov; 41(3):291-6. PubMed ID: 15334554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases.
    Chandra P; Luthra R; Zuo Z; Yao H; Ravandi F; Reddy N; Garcia-Manero G; Kantarjian H; Jones D
    Am J Clin Pathol; 2010 May; 133(5):686-93. PubMed ID: 20395514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.